|
|
|
1
|
A bill to be entitled |
2
|
An act relating to health care delivery and research; |
3
|
creating the Florida Center for Universal Research to |
4
|
Eradicate Disease within the Department of Health; |
5
|
providing legislative findings and intent; specifying the |
6
|
purpose and duties of the center; requiring an annual |
7
|
report to the Governor and Legislature; authorizing the |
8
|
department to outsource the duties of the center; creating |
9
|
an advisory council; amending s. 215.5602, F.S.; expanding |
10
|
the long-term goals of the James and Esther King |
11
|
Biomedical Research Program to include the cure of |
12
|
specified diseases; amending s. 215.5601, F.S., relating |
13
|
to the Lawton Chiles Endowment Fund, to conform; creating |
14
|
the Florida Cancer Research Cooperative; providing for a |
15
|
board of directors; providing the cooperative's mission |
16
|
and duties; requiring an annual report to the Florida |
17
|
Center for Universal Research to Eradicate Disease, the |
18
|
Governor, and the Legislature; creating the Florida Public |
19
|
Health Foundation, Inc.; providing the foundation's |
20
|
mission and duties; providing for a board of directors; |
21
|
requiring an annual report to the Florida Center for |
22
|
Universal Research to Eradicate Disease, the Governor, and |
23
|
the Legislature; requiring the foundation to coordinate |
24
|
monthly health awareness campaigns to disseminate |
25
|
information about specified diseases and conditions; |
26
|
providing an effective date. |
27
|
|
28
|
WHEREAS, stimulating activity in strategic sectors of the |
29
|
state's economy produces immeasurable and varied benefits for |
30
|
the people of this state, and |
31
|
WHEREAS, the health sector in particular, including areas |
32
|
such as biotechnology, medical technology, life sciences, and |
33
|
health care education, research, development, and delivery, |
34
|
represents an economic sector with tremendous potential to |
35
|
produce employment, financial, wellness, educational, cost- |
36
|
saving, and other benefits for the people of this state, and |
37
|
WHEREAS, stimulating activity in the health sector of the |
38
|
economy requires a comprehensive and synergistic policy approach |
39
|
that addresses coordinating biomedical and related research |
40
|
programs and opportunities; promoting the development of cures |
41
|
for diseases; facilitating advanced, world-class research in |
42
|
targeted fields of medical science; disseminating information on |
43
|
and increasing awareness of research innovations; and expanding |
44
|
educational opportunities in health and science fields, and |
45
|
WHEREAS, it serves a public purpose and furthers an |
46
|
essential government service to protect the health, safety, and |
47
|
welfare of Floridians, NOW, THEREFORE, |
48
|
|
49
|
Be It Enacted by the Legislature of the State of Florida: |
50
|
|
51
|
Section 1. Florida Center for Universal Research to |
52
|
Eradicate Disease.-- |
53
|
(1) The Legislature finds that an estimated 128 million |
54
|
Americans suffer from acute, chronic, and degenerative diseases |
55
|
and that biomedical research is the key to finding cures for |
56
|
these diseases that negatively affect all Floridians. The |
57
|
Legislature further finds that, while there is much research |
58
|
being conducted throughout this state and throughout the world, |
59
|
there is a lack of coordination of efforts among researchers. |
60
|
The Legislature, therefore, finds that there is a significant |
61
|
need for a coordinated effort if the goal of curing disease is |
62
|
to be achieved. Moreover, the Legislature finds that the |
63
|
biomedical technology sector meets the criteria of a high-impact |
64
|
sector, pursuant to section 288.108, Florida Statutes, having a |
65
|
high importance to this state's economy with a significant |
66
|
potential for growth and contribution to our universities and |
67
|
quality of life. |
68
|
(2) It is the intent of the Legislature that Florida |
69
|
strive to become the nation's leader in biomedical research and |
70
|
commit itself to being the state to find cures for the most |
71
|
deadly and widespread diseases. It is further the intent of the |
72
|
Legislature that there be a coordinated effort among the state's |
73
|
public and private universities and the biomedical industry to |
74
|
discover such cures. Moreover, it is the intent of the |
75
|
Legislature to expand the state economy by attracting biomedical |
76
|
researchers and research companies to this state. |
77
|
(3)(a) There is established within the Department of |
78
|
Health the Florida Center for Universal Research to Eradicate |
79
|
Disease, which shall be known as "CURED." |
80
|
(b) The purpose of the center is to coordinate, improve, |
81
|
expand, and monitor all biomedical research programs within the |
82
|
state, facilitate funding opportunities, and foster improved |
83
|
technology transfer of research findings into clinical trials |
84
|
and widespread public use. |
85
|
(c) The goal of the center is to find cures for diseases |
86
|
such as cancer, heart disease, lung disease, diabetes, |
87
|
autoimmune disorders, and neurological disorders, including |
88
|
Alzheimer's disease, epilepsy, and Parkinson's disease. |
89
|
(d) The center shall hold an annual biomedical technology |
90
|
summit in Florida to which biomedical researchers, biomedical |
91
|
technology companies, business incubators, pharmaceutical |
92
|
manufacturers, and others around the nation and world are |
93
|
invited to share biomedical research findings in order to |
94
|
expedite the discovery of cures. Summit attendees shall cover |
95
|
the costs of such attendance or obtain sponsorship for such |
96
|
attendance. |
97
|
(e) The center shall encourage clinical trials in this |
98
|
state on research that holds promise of curing a disease or |
99
|
condition. The center shall facilitate partnerships among |
100
|
researchers, treating physicians, and community hospitals for |
101
|
the purpose of sharing new techniques and new research findings, |
102
|
as well as coordinating voluntary donations to ensure an |
103
|
adequate supply of adult stem cells, placentas, or cord blood. |
104
|
(f) The center shall facilitate the formation of |
105
|
partnerships between researchers in this state and institutions |
106
|
in other states and countries where research with rare plants or |
107
|
animals could lead to cures. |
108
|
(g) The center shall encourage agricultural colleges and |
109
|
agricultural businesses in this state to be active in the search |
110
|
for cures and in providing information to the public about |
111
|
disease prevention. |
112
|
(h) The center shall facilitate partnerships among |
113
|
researchers working to cure all types of diseases, including |
114
|
those that are prevalent in developed countries and those that |
115
|
occur mainly in developing countries. |
116
|
(i) The center shall also encourage the discovery and |
117
|
production in Florida of vaccines that prevent disease. |
118
|
(j) The center shall monitor the supply and demand needs |
119
|
of researchers relating to stem cell research and other types of |
120
|
human tissue research. If the center determines that there is a |
121
|
need for increased donation of human tissue, it shall notify |
122
|
hospitals licensed pursuant to chapter 395, Florida Statutes, |
123
|
which have entered into partnership agreements with research |
124
|
institutes conducting stem cell research located in the same |
125
|
geographic region as the researchers demanding the stem cells or |
126
|
other tissues. Such hospitals shall implement programs that |
127
|
encourage voluntary donations of cord blood or other needed |
128
|
adult tissue. |
129
|
(k) The center shall be funded through private, state, and |
130
|
federal sources. |
131
|
(l) The center shall serve as a registry of all known |
132
|
opportunities for biomedical grants and may assist any public or |
133
|
private biomedical research program in this state in preparing |
134
|
grant requests. |
135
|
(m) The center shall maintain an Internet website with |
136
|
links to peer-reviewed biomedical research. The website shall |
137
|
also contain a list of all known biomedical research being |
138
|
conducted in Florida and shall facilitate communication among |
139
|
researchers and other interested parties. |
140
|
(n) The center shall submit an annual report to the |
141
|
Governor, the President of the Senate, and the Speaker of the |
142
|
House of Representatives no later than January 15 which contains |
143
|
recommendations for legislative change necessary to foster a |
144
|
positive climate for biomedical research in this state. |
145
|
(o) The Department of Health may outsource the duties of |
146
|
the center to a private entity or state university. |
147
|
(4)(a) There is established within the center an advisory |
148
|
council, which shall meet at least annually. |
149
|
(b) The council shall consist of the members of the board |
150
|
of directors of the Florida Research Consortium and at least one |
151
|
representative from: |
152
|
1. The Emerging Technology Commission. |
153
|
2. Enterprise Florida, Inc. |
154
|
3. BioFlorida. |
155
|
4. The Florida Biomedical Research Advisory Council. |
156
|
5. The Florida Medical Foundation. |
157
|
6. Pharmaceutical Research and Manufacturers of America. |
158
|
7. The Florida Tri-Agency Coalition on Smoking and Health. |
159
|
8. The Florida Cancer Research Cooperative, Inc. |
160
|
9. The American Cancer Society, Florida Division, Inc. |
161
|
10. The American Heart Association. |
162
|
11. The American Lung Association of Florida. |
163
|
12. The American Diabetes Association, South Coastal |
164
|
Region. |
165
|
13. The Alzheimer's Association. |
166
|
14. The Epilepsy Foundation. |
167
|
15. The National Parkinson Foundation. |
168
|
16. The Florida Public Health Foundation, Inc. |
169
|
17. Scripps Florida or the entity formed in this state by |
170
|
The Scripps Research Institute. |
171
|
(c) Members of the council shall serve without |
172
|
compensation, and each organization represented shall cover all |
173
|
expenses of its representative. |
174
|
Section 2. Paragraphs (a) and (b) of subsection (1) and |
175
|
subsections (2) and (10) of section 215.5602, Florida Statutes, |
176
|
are amended to read: |
177
|
215.5602 James and Esther King Biomedical Research |
178
|
Program.-- |
179
|
(1) There is established within the Department of Health |
180
|
the James and Esther King Biomedical Research Program funded by |
181
|
the proceeds of the Lawton Chiles Endowment Fund pursuant to s. |
182
|
215.5601. The purpose of the James and Esther King Biomedical |
183
|
Research Program is to provide an annual and perpetual source of |
184
|
funding in order to support research initiatives that address |
185
|
the health care problems of Floridians in the areas of tobacco- |
186
|
related cancer, cardiovascular disease, stroke, and pulmonary |
187
|
disease. The long-term goals of the program are to: |
188
|
(a) Improve the health of Floridians by researching better |
189
|
prevention, diagnoses, and treatments, and curesfor cancer, |
190
|
cardiovascular disease, stroke, and pulmonary disease. |
191
|
(b) Expand the foundation of biomedical knowledge relating |
192
|
to the prevention, diagnosis, and treatment, and cureof |
193
|
diseases related to tobacco use, including cancer, |
194
|
cardiovascular disease, stroke, and pulmonary disease. |
195
|
(2) Funds appropriated for the James and Esther King |
196
|
Biomedical Research Program shall be used exclusively for the |
197
|
award of grants and fellowships as established in this section; |
198
|
for research relating to the prevention, diagnosis, and |
199
|
treatment, and cureof diseases related to tobacco use, |
200
|
including cancer, cardiovascular disease, stroke, and pulmonary |
201
|
disease; and for expenses incurred in the administration of this |
202
|
section. Priority shall be granted to research designed to |
203
|
prevent or cure disease. |
204
|
(10) The council shall submit an annual progress report on |
205
|
the state of biomedical research in this state to the Florida |
206
|
Center for Universal Research to Eradicate Disease and tothe |
207
|
Governor, the Secretary of Health, the President of the Senate, |
208
|
and the Speaker of the House of Representatives by February 1. |
209
|
The report must include: |
210
|
(a) A list of research projects supported by grants or |
211
|
fellowships awarded under the program. |
212
|
(b) A list of recipients of program grants or fellowships. |
213
|
(c) A list of publications in peer reviewed journals |
214
|
involving research supported by grants or fellowships awarded |
215
|
under the program. |
216
|
(d) The total amount of biomedical research funding |
217
|
currently flowing into the state. |
218
|
(e) New grants for biomedical research which were funded |
219
|
based on research supported by grants or fellowships awarded |
220
|
under the program. |
221
|
(f) Progress in the prevention, diagnosis, and treatment, |
222
|
and cureof diseases related to tobacco use, including cancer, |
223
|
cardiovascular disease, stroke, and pulmonary disease. |
224
|
Section 3. Paragraph (d) of subsection (1) of section |
225
|
215.5601, Florida Statutes, is amended to read: |
226
|
215.5601 Lawton Chiles Endowment Fund.-- |
227
|
(1) LEGISLATIVE INTENT.--It is the intent of the |
228
|
Legislature to: |
229
|
(d) Provide funds to help support public-health and |
230
|
biomedical research for the prevention, diagnosis, and |
231
|
treatment, and cureof diseases related to tobacco use by |
232
|
creating an annual and perpetual source of funding for |
233
|
biomedical research in the state in order to expand the |
234
|
foundation of biomedical knowledge relating to the prevention, |
235
|
diagnosis, and treatment, and cureof diseases related to |
236
|
tobacco use, including cancer, cardiovascular disease, stroke, |
237
|
and pulmonary disease; improve the quality of the state's |
238
|
academic health centers by bringing the advances of biomedical |
239
|
research into the training of physicians and other health care |
240
|
providers; and increase the state's per capita funding for |
241
|
biomedical research by undertaking new initiatives in biomedical |
242
|
research which will attract additional funding from outside the |
243
|
state while also stimulating economic activity in the state in |
244
|
areas related to biomedical research, such as the research and |
245
|
production of pharmaceuticals, biotechnology, and medical |
246
|
devices. |
247
|
Section 4. Florida Cancer Research Cooperative.-- |
248
|
(1) Effective July 1, 2004, the Florida Cancer Research |
249
|
Cooperative is established for the purpose of making the State |
250
|
of Florida a world-class center for cancer research. |
251
|
(2)(a) A not-for-profit corporation, acting as an |
252
|
instrumentality of the Florida Dialogue on Cancer, shall be |
253
|
organized for the purpose of governing the affairs of the |
254
|
cooperative. |
255
|
(b) The Florida Cancer Research Cooperative, Inc., may |
256
|
create not-for-profit corporate subsidiaries to fulfill its |
257
|
mission. The not-for-profit corporation and its subsidiaries may |
258
|
receive, hold, invest, and administer property and any moneys |
259
|
acquired from private, local, state, and federal sources, as |
260
|
well as technical and professional income generated or derived |
261
|
from the mission-related activities of the cooperative. |
262
|
(c) The affairs of the not-for-profit corporation shall be |
263
|
managed by a board of directors, which shall consist of: |
264
|
1. The Secretary of Health or his or her designee. |
265
|
2. The Chief Executive Officer of the H. Lee Moffitt |
266
|
Cancer Center or his or her designee. |
267
|
3. The President of the University of Florida Shands |
268
|
Cancer Center or his or her designee. |
269
|
4. The Chief Executive Officer of the University of Miami |
270
|
Sylvester Comprehensive Cancer Center or his or her designee. |
271
|
5. The Chief Executive Officer of the Mayo Clinic, |
272
|
Jacksonville, or his or her designee. |
273
|
6. The Chief Executive Officer of the American Cancer |
274
|
Society, Florida Division, or his or her designee. |
275
|
7. The President of the American Cancer Society, Florida |
276
|
Division Board of Directors, or his or her designee. |
277
|
8. The President of the Florida Society of Clinical |
278
|
Oncology or his or her designee. |
279
|
9. The Chief Executive Officer of Enterprise Florida, |
280
|
Inc., or his or her designee. |
281
|
10. Three representatives from large Florida hospitals or |
282
|
institutions, not delineated in subparagraphs 2.-5., which treat |
283
|
a large volume of cancer patients. One shall be appointed by the |
284
|
Governor, one shall be appointed by the President of the Senate, |
285
|
and one shall be appointed by the Speaker of the House of |
286
|
Representatives. |
287
|
11. Three representatives from community-based, statewide |
288
|
organizations serving populations that experience cancer |
289
|
disparities, one of whom shall be appointed by the Governor, one |
290
|
of whom shall be appointed by the President of the Senate, and |
291
|
one of whom shall be appointed by the Speaker of the House of |
292
|
Representatives. |
293
|
12. One member of the Florida House of Representatives, to |
294
|
be appointed by the Speaker of the House of Representatives. |
295
|
13. One member of the Florida Senate, to be appointed by |
296
|
the President of the Senate. |
297
|
14. Three university presidents, one of whom shall be |
298
|
appointed by the Governor, one of whom shall be appointed by the |
299
|
President of the Senate, and one of whom shall be appointed by |
300
|
the Speaker of the House of Representatives. |
301
|
15. Five representatives from other statewide public |
302
|
health organizations whose missions include public education and |
303
|
the eradication of cancer, three of whom shall be appointed by |
304
|
the Governor, one of whom shall be appointed by the President of |
305
|
the Senate, and one of whom shall be appointed by the Speaker of |
306
|
the House of Representatives. |
307
|
(d) Appointments made by the Speaker of the House of |
308
|
Representatives and the President of the Senate pursuant to |
309
|
paragraph (c) shall be for 2-year terms, concurrent with the |
310
|
bienniums in which they serve as presiding officers. |
311
|
(e) Appointments made by the Governor pursuant to |
312
|
paragraph (c) shall be for 2-year terms, although the Governor |
313
|
may reappoint directors. |
314
|
(f) Members of the board of directors of the not-for- |
315
|
profit corporation or any subsidiaries shall serve without |
316
|
compensation. |
317
|
(3) The cooperative shall issue an annual report to the |
318
|
Florida Center for Universal Research to Eradicate Disease and |
319
|
to the Governor, the Speaker of the House of Representatives, |
320
|
and the President of the Senate, by December 15 of each year, |
321
|
with policy and funding recommendations regarding cancer |
322
|
research capacity in Florida and related issues. |
323
|
Section 5. Florida Cancer Research Cooperative; mission |
324
|
and duties.-- |
325
|
(1) The cooperative shall develop and centralize the |
326
|
processes and shared services for expanding cancer research in |
327
|
Florida through: |
328
|
(a) Support through bioinformatics, in order to create a |
329
|
cancer informatics infrastructure that enhances information and |
330
|
resource exchange and integration through researchers working in |
331
|
diverse disciplines to facilitate the full spectrum of cancer |
332
|
investigations. |
333
|
(b) Technical coordination, business development, and |
334
|
support of intellectual property. |
335
|
(c) Development of a statewide cancer clinical trials |
336
|
network as contemplated in section 1. |
337
|
(d) Other activities to support multidisciplinary |
338
|
research. |
339
|
(2) The cooperative shall work in concert with the Florida |
340
|
Center for Universal Research to Eradicate Disease created in |
341
|
section 1 to ensure that the goals of the center are advanced. |
342
|
Section 6. The Florida Public Health Foundation, Inc.; |
343
|
establishment; purpose; mission; duties; board of directors.-- |
344
|
(1) The Florida Public Health Foundation, Inc., otherwise |
345
|
referred to in this section as "corporation," is established for |
346
|
the purpose of disseminating breakthrough findings in biomedical |
347
|
research and promoting health awareness in this state. |
348
|
(2) The corporation's mission includes disseminating |
349
|
information about innovative biomedical research and clinical |
350
|
trials in this state as well as making Floridians and their |
351
|
treatment providers aware of specified diseases and conditions |
352
|
and available methods of preventing, diagnosing, treating, and |
353
|
curing those diseases and conditions. |
354
|
(3) The purpose and objective of the corporation shall be |
355
|
to operate exclusively for charitable, scientific, and |
356
|
educational purposes; to protect and improve the health and |
357
|
well-being of Florida's people and environment through |
358
|
partnerships committed to program innovation, education, applied |
359
|
research, and policy development; and to engage in charitable |
360
|
programs dedicated to improving the health of Floridians. |
361
|
(4) The corporation shall be established as a not-for- |
362
|
profit entity qualifying under section 501(c)(3) of the Internal |
363
|
Revenue Code. The corporation may receive, hold, invest, and |
364
|
administer property and any moneys acquired from private, local, |
365
|
state, and federal sources, as well as technical and |
366
|
professional income generated or derived from the mission- |
367
|
related activities of the corporation. The corporation shall |
368
|
have all of the powers conferred upon corporations organized |
369
|
under chapter 617, Florida Statutes. |
370
|
(5) The corporation's duties include procuring funds |
371
|
necessary for accomplishing the purpose and mission of the |
372
|
corporation. The corporation shall strive to complement, |
373
|
supplement, and enhance the missions of the various |
374
|
organizations, entities, and departments represented on its |
375
|
board by serving as the lead corporation in the state for |
376
|
promoting public health awareness. |
377
|
(6) The affairs of the corporation shall be managed by an |
378
|
executive director appointed by a board of directors consisting |
379
|
of: |
380
|
(a) The Secretary of Health or his or her designee. |
381
|
(b) A former member of the Senate appointed by the |
382
|
President of the Senate. |
383
|
(c) A former member of the House of Representatives |
384
|
appointed by the Speaker of the House of Representatives. |
385
|
(d) A representative of the American Heart Association. |
386
|
(e) A representative of the American Cancer Society, |
387
|
Florida Division, Inc. |
388
|
(f) A representative of the American Lung Association of |
389
|
Florida. |
390
|
(g) A representative of the American Diabetes Association, |
391
|
South Coastal Region. |
392
|
(h) A representative of the Alzheimer's Association. |
393
|
(i) A representative of the Epilepsy Foundation. |
394
|
(j) A representative of the National Parkinson Foundation. |
395
|
(k) A representative of the March of Dimes, Florida |
396
|
Chapter. |
397
|
(l) A representative of the Arthritis Foundation, Florida |
398
|
Chapter. |
399
|
(m) A representative of the American Liver Foundation. |
400
|
(n) A representative of the Florida Council for Behavioral |
401
|
Healthcare, Inc. |
402
|
(o) A representative of the Florida Alcohol and Drug Abuse |
403
|
Association, Inc. |
404
|
(p) A representative of Pharmaceutical Research and |
405
|
Manufacturers of America. |
406
|
(q) A representative of the Florida Public Health |
407
|
Association. |
408
|
(r) A representative of the Florida Association of County |
409
|
Health Officers. |
410
|
(s) A public health academician selected by the state |
411
|
health officer. |
412
|
(t) A representative of the Florida Academy of Family |
413
|
Physicians. |
414
|
(u) Three consumers who have demonstrated an interest in |
415
|
protecting the public health appointed by the Florida Public |
416
|
Health Association. |
417
|
(7) Members of the board of directors shall serve for 2- |
418
|
year terms and shall serve without compensation. |
419
|
(8) The corporation, in consultation with the Department |
420
|
of Health and the Florida Center for Universal Research to |
421
|
Eradicate Disease, shall facilitate communication between |
422
|
biomedical researchers and health care providers each month |
423
|
according to the health awareness schedule established by the |
424
|
corporation, in order to ensure ongoing dialogue among |
425
|
researchers, treatment providers, and the department. |
426
|
(9) The corporation and the Department of Health shall |
427
|
enter into partnerships with providers of continuing education |
428
|
for health care practitioners, including, but not limited to, |
429
|
hospitals and state and local medical organizations, to ensure |
430
|
that practitioners are aware of the most recent and complete |
431
|
diagnostic and treatment tools. |
432
|
(10) The corporation shall provide an annual report |
433
|
concerning its activities and finances to the Florida Center for |
434
|
Universal Research to Eradicate Disease by December 15 and shall |
435
|
provide copies of the annual report to the Governor, the |
436
|
President of the Senate, and the Speaker of the House of |
437
|
Representatives. |
438
|
Section 7. Health awareness campaigns.-- |
439
|
(1) The Florida Public Health Foundation, Inc., in |
440
|
consultation with the Department of Health, shall coordinate |
441
|
monthly health awareness campaigns with national, state, and |
442
|
local health care organizations and government entities |
443
|
targeting a wide range of the public, including: parents; |
444
|
teachers and other school employees; students in grades 4-12, |
445
|
colleges, and universities; state agency employees; county and |
446
|
local government employees; patients of county health |
447
|
departments; Medicaid recipients; health care professionals and |
448
|
providers; and the public in general. |
449
|
(2) The awareness campaigns shall include the provision of |
450
|
educational information about preventing, detecting, treating, |
451
|
and curing the following diseases or conditions. Additional |
452
|
diseases and conditions that impact the public health may be |
453
|
added by the board of directors of the Florida Public Health |
454
|
Foundation, Inc. However, each of the following diseases or |
455
|
conditions must be included in an awareness campaign during at |
456
|
least 1 month in any 24-month period: |
457
|
(a) Cancer, including breast, prostate, cervical, ovarian, |
458
|
colorectal, and skin cancer and leukemia. |
459
|
(b) Heart disease. |
460
|
(c) Stroke. |
461
|
(d) Lung disease, including asthma and smoking-related |
462
|
disease. |
463
|
(e) Neurological disorders and disease, including |
464
|
Alzheimer's disease, Parkinson's disease, and epilepsy. |
465
|
(f) Gastrointestinal disease. |
466
|
(g) Kidney disease. |
467
|
(h) Diabetes. |
468
|
(i) Liver disease. |
469
|
(j) Autoimmune disorders. |
470
|
(k) Birth defects and prenatal care. |
471
|
(l) Obesity and malnutrition. |
472
|
(m) Sexually transmissible disease. |
473
|
(n) Hepatitis A, hepatitis B, and hepatitis C. |
474
|
(o) Arthritis. |
475
|
(p) Vaccine-preventable diseases. |
476
|
(q) Infectious diseases, including HIV/AIDS. |
477
|
(r) Substance abuse. |
478
|
(s) Mental illness. |
479
|
(3) The health awareness campaigns shall be funded by the |
480
|
Florida Public Health Foundation, Inc., and the Department of |
481
|
Health to the extent that funds are available from public and |
482
|
private sources. |
483
|
(4) Health awareness information shall be disseminated |
484
|
through all available methods, including print, audio, visual, |
485
|
and electronic media. |
486
|
Section 8. This act shall take effect upon becoming a law. |